OTCMKTS:EMHTF Emerald Health Therapeutics (EMHTF) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free EMHTF Stock Alerts $0.04 +0.01 (+55.17%) (As of 11/11/2022) Add Compare Share Share Today's Range$0.03▼$0.0450-Day Range$0.04▼$0.0452-Week Range$0.02▼$0.09Volume1.05 million shsAverage Volume116,962 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Emerald Health Therapeutics alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Emerald Health Therapeutics Stock (OTCMKTS:EMHTF)Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.Read More EMHTF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EMHTF Stock News HeadlinesFebruary 16, 2024 | npr.orgShotsOctober 6, 2023 | health.usnews.comEmerald D. RobinsonApril 24, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.January 12, 2023 | finance.yahoo.comEmerald Health Pharmaceuticals Receives Safety Review Committee Approval to Proceed to Final Cohorts of EHP-101 Phase 2a Systemic Sclerosis TrialNovember 9, 2022 | finance.yahoo.comIIROC Trading Halt - EMHNovember 7, 2022 | finance.yahoo.comEmerald Health Therapeutics and Skye Bioscience Announce Intended Closing Date of Plan of ArrangementSeptember 2, 2022 | seekingalpha.comEmerald Health Therapeutics Q2 GAAP EPS of -C$0.01, revenue of C$1.28MAugust 23, 2022 | finance.yahoo.comHYTN Awarded Medical Cannabis Sales Licence Increasing Opportunities at Kelowna FacilityApril 24, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.August 12, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Restates Q1 Financial Statements to Meet PCAOB StandardAugust 12, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Provides Update on and Additional Background to Transaction with Skye BioscienceJuly 13, 2022 | finanznachrichten.deEmerald Health Therapeutics, Inc.: Emerald Health Therapeutics Announces Revocation of Management Cease Trade OrderJuly 11, 2022 | nz.finance.yahoo.comEMERALD HEALTH SCIENCES INC.June 3, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Provides Second Bi-Weekly MCTO Status UpdateMay 12, 2022 | finance.yahoo.comEmerald Health Therapeutics Signs Arrangement Agreement with Skye BioscienceMay 6, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Transfers US Listing to OTCQBApril 28, 2022 | finance.yahoo.comEmerald Health Therapeutics, Inc. Applies for Management Cease Trade OrderMarch 17, 2022 | msn.comHYTN Innovations To Accept Cannabis Orders Directly From Provinces & TerritoriesMarch 17, 2022 | finance.yahoo.comHYTN Begins Accepting Orders Directly from Provinces and TerritoriesFebruary 22, 2022 | benzinga.comHYTN Innovations Receives Health Canada's Approval To Sell CannabisFebruary 22, 2022 | finance.yahoo.comHYTN Innovations Awarded Approval for the Sale of Cannabis to Provincially and Territorially Authorized RetailersJanuary 11, 2022 | nz.finance.yahoo.comEmerald Health Pharmaceuticals Receives IND Clearance to Begin Phase 2 Clinical Trial of EHP-101 for Relapsing Forms of Multiple SclerosisJanuary 11, 2022 | finance.yahoo.comEmerald Health Therapeutics Sells Patents to FlowerPodJanuary 4, 2022 | benzinga.comEmerald Holdings Buys MJBiz For $120M, Signaling Widespread Acceptance Of Booming Cannabis IndustryDecember 5, 2021 | stockhouse.comEmerald Health Therapeutics Inc EMHTFDecember 1, 2021 | benzinga.comRiaz BandaliOctober 28, 2021 | benzinga.comEmerald Health's Partner, Flower Pod, Launches Unique Dose-Controlled Cannabis VaporizerSee More Headlines Receive EMHTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorOils/Energy Industry Oil & Gas Production Sub-IndustryN/A Current SymbolOTCMKTS:EMHTF CUSIPN/A CIK1768225 Webwww.emerald.care Phone(800) 757-3536FaxN/AEmployees110Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Mohammed JiwanChief Operating OfficerMr. Bernie HertelVP of Fin. and CommunicationsMs. Rebecca WongSr. VP of Quality & Regulatory AffairsKey CompetitorsGASFRAC Energy ServicesOTCMKTS:GSFVFLeucrotta ExplorationOTCMKTS:LCRTFSeven Generations EnergyOTCMKTS:SVRGFSpyglass ResourcesOTCMKTS:PACEFTORC Oil & GasOTCMKTS:VREYFView All Competitors EMHTF Stock Analysis - Frequently Asked Questions How have EMHTF shares performed in 2024? Emerald Health Therapeutics' stock was trading at $0.0405 at the beginning of the year. Since then, EMHTF stock has increased by 0.0% and is now trading at $0.0405. View the best growth stocks for 2024 here. How do I buy shares of Emerald Health Therapeutics? Shares of EMHTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EMHTF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm PressNew Trump BombshellThe Freeport SocietyThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emerald Health Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
